Home » ESPACOMP and ENABLE collaboration – in 26th ESPACOMP Conference, Berlin (Germany), November, 2022

ESPACOMP and ENABLE collaboration – in 26th ESPACOMP Conference, Berlin (Germany), November, 2022

Many of ENABLE project members were present to 26th ESPACOMP Conference in Berlin (Germany), 17-19 November 2022.

There were presented results of the activities during ENABLE project:

  • Development and evaluation of medication adherence technologies: Generating guidance for ENABLE repository users. Ribaut J, Nabergoj Makovec U, Goetzinger C, Barnestein-Fonseca P, Haupenthal  F, Herdeiro MT,
    Jácome  C, Roque F, Smits D, Tadic I, Dima AL
  • The importance of communication and dissemination in a European project on medication adherence. Hafez G, Goetzinger C, Ghiciuc C, Menditto E, Leiva Fernandez F, Dimitrova M, Herdeiro MT, Leiva VA, Wettermark B
  • Actions to improve medication adherence during the COVID-19 pandemic in Europe. Aarnio E, Mucherino S, Mihajlović J, Hafez G, Kamusheva M, Leiva-Fernández F, Qvarnström M, Ekenberg M, Trečiokienė I, Potočnjak I

ENABLE project members also presented other results of their work on adherence:

  • Promoting medication adherence: complex interventions and challenging implementation. Prof. Dr. Hilary Pinnock
  • Reinitiation of statins in patients with peripheral arterial disease. Wawruch M, Murin J, Petrova M, Trnka M, Tesar T
  • A contextual analysis and implementation plan for a pharmacist-led medication adherence program. Kelly A, Bossina S, Chan L, Frade S, Rezae F, Shakir M, Schneider MP
  • Longitudinal trajectory modeling to assess adherence to Sacubitril / Valsartan among patients with Heart Failure. Mucherino S, Dima AL, Orlando V, Menditto E
  • Objective metrics of habit strength are associated with adherence. Pironet A, Phillips LA, Vrijens B
  • Shared decision making and associated medication adherence in patients with COPD and/or asthma. Achterbosch M, van Dijk L, van Boven JFM
  • 12-year evolution of immunosuppressant non-adherence in adult kidney trans-plantation recipients: The Swiss Transplant Cohort Study Meury, P, De Geest, S, Denhaerynck, K, Dickenmann, M, Stürzinger, U, Huynh-Do, U, Binet, F-I, Künzler-Heule, P, Boehler, A, Beerli, N, Ribaut, J
  • Open and standardised estimation and visualisation of medication adherence: new developments in AdhereR Dima, AL, Allemann, S, Dediu, D
  • Adherence to palbociclib and omitted doses management supported by pharmacometric modeling. Bandiera C, Locatelli I, Courlet P, Cardoso E, Zaman K, Stravodimou A, Sarivalasis A, Aedo-Lopez V, Zurcher JP, Guidi M, Wagner D, Csajka C, Schneider MP
  • Patient’s Experiences with Multidose Drug Dispensing – A Qualitative Study. Josendal AV, Bergmo TS, Granas AG
  • Salivary drug concentrations and adherence: currently used analytical methods. Ghiciuc CM, Velescu B, Ochiuz L
  • Impact of Direct-Acting Antivirals Adherence on Cure Rate in Chronic Hepatitis C Virus. Turcu-Stiolica A, Doica IP, Ungureanu BS, Rogoveanu I, Subtirelu MS, Gheonea DI
  • Effects of COVID-19 pandemic on healthcare services availability: cross‑sectional online survey in Poland. Kardas P, Lewek P.
  • The impact of war on maintenance of long-term therapies in Ukraine. Khanyk N, Hromovyk B, Agh T, Wettermark B, Kardas P

See more: